Importantly, loss of myeloid Abca1 alone was sufficient to significantly inhibit tumor development (p=0.01), and additional deletion of Abcg1 in the same immune cells did not lead to enhanced suppression of tumor growth (Figure 2A). Here, ABCG1 is linked to neoplasm.